Primrose Bio launches following merger of Primordial Genetics and Pelican Technology Holdings with $15 million in funding from Ligand Pharmaceuticals SAN DIEGO, Sept. 18, 2023 /PRNewswire/ — Primrose Bio, Inc., a stand-alone private biotechnology company focused on developing…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.